1158797-00-2

Upstream product

• 1158796-90-7 phenyl 4,6-O-di(tert-butyl)silylidene-1,2-dideoxy-3-O-levulinoyl-2-trichloroacetamido-1-thio-β-D-glucopyranoside 
• 725228-76-2 methyl (phenyl 2,3-di-O-benzoyl-1-thio-β-D-glucopyranosid)uronate 
• 1154463-83-8 4,6-O-di-tert-butylsilylidene-3-O-levulinoyl-1-O-(N-phenyltrifluoroacetimidoyl)-2-N-trichloroacetamido-α/β-D-glucopyranoside 
• 123-76-2 levulinic acid 
• 90-76-6 2-deoxy-2-amino glucose 

Downstream Products

• 1158797-04-6 C₆₁H₈₃Cl₆N₅O₂₁Si₂ 
• 1158797-06-8 C₉₈H₁₂₇Cl₉N₆O₃₄Si₃ 
• 1158797-08-0 C₁₃₅H₁₇₁Cl₁₂N₇O₄₇Si₄ 
• 1319721-65-7 methyl (2,3-dibenzoyl-4-O-(4,6-O-di-tert-butylsilandiyl-2-deoxy-3-O-levulinoyl-2-trichloroacetamido-β-D-glucopyranosyl)-β-D-glucopyranoside N-phenyl-2,2,2-trifluoroacetimidate)uronate 
• 1319721-76-0 C₄₂H₅₂Cl₃NO₁₆Si 

Relevant academic research and scientific papers

Automated solid-phase synthesis of hyaluronan oligosaccharides

Well-defined fragments of hyaluronic acid (HA) have been obtained through a fully automated solid-phase oligosaccharide synthesis. Disaccharide building blocks, featuring a disarmed glucuronic acid donor moiety and a di-tert-butylsilylidene-protected gluc

Synthesis of hyaluronic acid oligomers using chemoselective and one-pot strategies

(Chemical Equation Presented) An efficient synthetic strategy toward a hyaluronic acid (HA) tri-, penta-, and heptamer having a glucosamine-reducing end is reported. The synthesis is based on a glucuronate ester thioglycoside and a trifluoro-N-phenylimida